Search Results

Blood Cancer United Named to Inaugural “Best Companies for Working with Cancer” Index

Blood Cancer United® has been named one of the inaugural Best Companies for Working with Cancer, a national recognition from Cancer and Careers, the l…

High School Students Kick off Philanthropic Competition to Help All Blood Cancer Patients

WASHINGTON, Jan.

New Research for the Holidays Shows It Is Better to Give Than Receive

View full multimedia release here

Cancer Treatment: How to Make Informed Choices About Cancer Treatment and Clinical Trials

Cancer Treatment: How to Make Informed Choices About Cancer Treatment and Clinical Trials Thursday, June , Sycamore House Restaura…

Celebrating Diversity Fueled High School Students to Break Fundraising Records for Cancer Cures

(RYE BROOK, NY, July , ) - The effects of the pandemic are far reaching, and high school students are among those whose lives are being . Not only is…

Biomarker and Risk Tailored Treatment to Improve Outcomes in Diffuse Large B-cell Lymphoma

Improving survival for patients with diffuse large lymphoma requires tailoring treatment to lymphoma genetic heterogeneity, addressing minimal residu…

FDA Approves a CAR T-cell Therapy to Treat Adults with a Form of Acute Leukemia

The Leukemia & Lymphoma Society (LLS) was an early champion and funder of CAR therapy RYE BROOK, N.Y., December , – The U.S. Food and Drug Administr…

FDA Approves Drug Designed to Target Specific Mutation in Rare Blood Cancer Type

The Leukemia & Lymphoma Society has provided funding to research that identified novel ways to attack the IDH mutation in patients with blood cancers.…

FDA Approves First of a New Class of Drugs to Treat Advanced Acute Leukemia

The Leukemia & Lymphoma Society (LLS) helped every step of the way in discovery and development of menin inhibitors RYE BROOK, N.Y., December , – The…

New $20 Million Research Funding Program Aims to ‘Accelerate a Cure’ for Follicular Lymphoma

The Leukemia & Lymphoma Society and the Institute for Follicular Lymphoma Innovation commit $ million to jointly fund follicular lymphoma research.RYE…

Research Funds Available for Studies Designed to Increase Cancer Clinical Trial Accrual & Access

THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) IS ACCEPTING APPLICATIONS FOR RESEARCH STUDIES DESIGNED TO HELP INCREASE CANCER CLINICAL TRIAL ACCRUAL AND ACCES…

FDA Approves New Option for Difficult to Treat, Rare Form of Childhood Leukemia

The Food and Drug Administration (FDA) recently approved azacitidine (Vidaza®) for pediatric patients month and older with newly diagnosed juvenile m…

LLS is Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling

LLS Remains Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling

Shred For Red: An Unstoppable Community Hits the Slopes to End Blood Cancer

(RYE BROOK, N.Y., November , ) - The Leukemia & Lymphoma Society's (LLS) is kicking off the ski season in an impactful way. Olympians from across the…

A Panel Discussion on Transitioning Your Student Back to School: Practical Tips and Advice

Watch this informative panel discussion of school personnel for practical tips on supporting a student attending school during or after cancer treatme…

Investigating the role of preleukemia duration and clonal burden in progression to AML

The development of acute myeloid leukemia (AML) is preceded by a “preleukemic” phase in which mutated hematopoietic stem cells expand due to a fitness…

Memory-like natural killer cells and venetoclax to eradicate measurable residual disease in AML

This proposal is to conduct a phase I (early phase) clinical trial to test whether the combination of the approved targeted therapy venetoclax with N…

Understanding molecular determinants of immune evasion to CAR-T cells at single clone resolution

Cellular immunotherapies such cells are now firmly established as major pillars of therapy particularly in malignancies. However, despite their rem…

NK cell immunotherapy to reduce relapse after haploidentical transplant for high-risk pediatric AML

Leukemia recurrence remains the most common type of treatment failure after allogeneic hematopoietic cell transplant for children and young adults wit…

Suggested Reading - Childhood Cancer Survivors: A Practical Guide to Your Future, 3rd Ed.

The treatments used to cure cancer in children can affect their growing bodies and developing minds. This book provides information on medical late ef…

LLS and 30 patient organizations take action to protect patients from substandard insurance

Health insurance is supposed to protect patients when they need help the most. When it works for patients the way it’s supposed to, it keeps their cos…

Reaching out to underserved & minority patients with hematological diseases in the southeastern US

Cancer Center (VICC) is the only NCI designated cancer center that serves both adult and pediatric populations in TN, one of the highest states in th…

Clinical investigation to improve efficacy of CAR-T Cell Therapy for Large B Cell Lymphoma

We are investigating new interventions that could improve the effectiveness of CAR therapy for lymphoma. A clinical trial will test radiation immedia…

More Than 5 Million New Yorkers Are Getting "In-Network" Access to Top Cancer Centers

TAP Biotech Partner ImCheck Therapeutics to be Acquired by Ipsen in €1B deal

Ipsen and ImCheck Therapeutics announced they have entered into a definitive agreement in which Ipsen will acquire ImCheck Therapeutics, a private Fre…